Definitive Healthcare Corp (OQ:DH)
Business Focus: Software
| Sector: Technology | Industry: Software |
| See Regulatory Filings on SEC | |
| Company Contact | |
| Address: | 492 Old Connecticut Path, Suite 401 FRAMINGHAM MA 01701 |
| Tel: | N/A |
| Website: | https://ir.definitivehc.com |
| IR: | See website |
| Key People | ||
| Jason Ronald Krantz Executive Chairman of the Board, Interim Chief Executive Officer, Founder | Jonathan Maack President | Richard D. Booth Chief Financial Officer |
| Carrie Lazorchak Chief Revenue Officer | Kate Marie Shamsuddin Jensen Chief Product Officer | |
| Business Overview |
| Definitive Healthcare Corp. is engaged in transforming data, analytics, and expertise into healthcare commercial intelligence. The Company's solutions are designed to provide information on healthcare providers and their activities to help its customers optimize everything from product development to go-to-market planning and sales and marketing execution. Its software-as-a-service (SaaS) platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers and improving win rates with detailed contextual information. It transforms data into intelligence through artificial intelligence (AI) and machine learning (ML) algorithms that ingest, cleanse, link, and analyze the data to create new intelligence and analytics. All of its business is conducted through AIDH TopCo, LLC (Definitive OpCo). |
| Financial Overview |
| For the fiscal year ended 31 December 2023, Definitive Healthcare Corp revenues increased 13% to $251.4M. Net loss increased from $7.2M to $202.4M. Revenues reflect Platform subscriptions segment increase of 12% to $243.1M, Professional services segment increase of 49% to $8.4M, United States segment increase of 13% to $239.5M, Rest of world segment increase of 9% to $12M. |
| Employees: | 830 as of Jan 31, 2024 |
| Reporting Currency: | U.S. Dollars |
| Enterprise value: | $777.48M as of Dec 31, 2023 |
| Annual revenue (TTM): | $251.42M as of Dec 31, 2023 |
| EBITDA (TTM): | $26.11M as of Dec 31, 2023 |
| Net annual income (TTM): | -$202.39M as of Dec 31, 2023 |
| Free cash flow (TTM): | $38.21M as of Dec 31, 2023 |
| Net Debt Last Fiscal Year: | N/A |
| Shares outstanding: | 156,957,232 as of Mar 25, 2024 |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.